Form 4 for ALT Altimmune, Inc.
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001104659-23-011211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-06 | 2023-02-02 | ALT | Harris Matthew Scott | Chief Medical Off | M - OptEx | $0.00 | +7,775 | 25.7K | +43% | $0 |
| D | 2023-02-06 | 2023-02-02 | ALT | Harris Matthew Scott | Chief Medical Off | F - Tax | $15.04 | -2,364 | 23.3K | -9% | -$35.6K |
| D | 2023-02-06 | 2023-02-02 | ALT | Harris Matthew Scott | Chief Medical Off | M - OptEx | $0.00 | -7,775 | 23.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2023-02-02 | M | A | 7,775 | $0.00 | 25,675 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. |
| 2 | Common | Common Stock, par value $0.0001 | 2023-02-02 | F | D | 2,364 | $15.04 | 23,311 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-02 | M | D | 7,775 | $0.00 | 23,325 | D | — · — to — | 7,775 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |